ReviewJournal of biochemical and molecular toxicology2022

CRISPR-based point-of-care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes advanced for SARS-CoV-2 detection.

Monika K Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.